Denne side blev automatisk oversat, og nøjagtigheden af ​​oversættelsen er ikke garanteret. Der henvises til engelsk version for en kildetekst.

Vurdering af AI-understøttet frakturdetektion i akutafdelinger (FAIR)

3. november 2026 opdateret af: Martin Breitwieser, Salzburger Landeskliniken

Evaluering af omkostningseffektiviteten og virkningen af ​​workflowet af AI-understøttet frakturdetektion i en ortopædisk akutafdeling

This study evaluates whether artificial intelligence (AI) can support doctors who interpret X-rays for suspected fractures in emergency care.

In the participating hospitals, X-rays are usually interpreted first by the frontline treating physician, while the formal radiology report is generally available later and not before the patient leaves the emergency department. AI may therefore provide an immediate additional assessment while clinical decisions are being made.

Patients were randomly assigned to one of two groups. In the AI-assisted group, physicians interpreted the X-rays with support from an AI system. In the control group, physicians interpreted the same type of X-rays without AI support. All final diagnoses and treatment decisions remained with the treating physician.

The main question is whether AI assistance affects the time from emergency department triage to discharge. The study also evaluates whether AI influences physician diagnostic confidence, the use of additional imaging, missed fractures, and diagnostic accuracy.

The study included patients aged 2 years or older presenting with an isolated musculoskeletal injury or relevant joint complaint requiring X-ray imaging. No additional imaging or treatment was required solely because of study participation.

Studieoversigt

Status

Afsluttet

Betingelser

Detaljeret beskrivelse

The FAIR (Fracture detection with AI in emergency Radiography) Trial was a prospective, international, multicentre, pragmatic randomised controlled trial evaluating the clinical impact of artificial intelligence (AI)-assisted interpretation of musculoskeletal radiographs in routine emergency care. The study was conducted across four clinical units at three hospitals in Austria and Germany.

Clinical workflow and randomisation

In the participating departments, radiographs were interpreted by frontline orthopaedic trauma or paediatric physicians, who made immediate diagnostic and treatment decisions. Formal radiology reports were generally available later. The intervention therefore evaluated AI as an additional decision-support tool rather than as a replacement for physician interpretation. Patient encounters were individually randomised using a single sequence generated by the trial statistician. Allocation was concealed using folded, sequentially numbered study forms and revealed after radiography. Patients were then directed to designated AI-assisted or control treatment areas. All clinical decisions remained the responsibility of the treating physician.

AI implementation

The intervention used BoneView version 2.3.8 (Gleamer, Paris, France), which provided visual annotations and classifications for fractures, focal bone lesions, dislocations, and joint effusions. The software version remained unchanged throughout recruitment. At Salzburg and Hallein, BoneView was delivered through Aidoc aiOS version 3.24.0; at Nuremberg, it was integrated through Visage version 7.1.19. Participating physicians received standardised training before using the system. AI output was documented on study case-report forms, although detailed software telemetry on actual viewing behaviour was unavailable.

Protocol evolution

During recruitment, an exploratory unblinded analysis in October 2025 examined prospectively collected clinical and workflow outcomes. Following methodological feedback during the Austrian Science Fund review process in March 2026, the outcome hierarchy for the fracture-focused clinical-effectiveness analysis was revised in consultation with the trial statistician, prioritising time from emergency department triage to discharge over diagnostic accuracy. The amendment did not alter randomisation, clinical procedures, or data collection. The originally registered cost-efficiency outcome was discontinued because the available data did not permit a reliable health-economic evaluation.

Reference standard

For fracture-related diagnostic analyses, a radiologist experienced in musculoskeletal imaging and a senior orthopaedic trauma surgeon reviewed the index radiographs and available clinical information. Disagreements were resolved by consensus or, when necessary, by a third expert. The assessment distinguished fractures visible on the original radiographs from fractures detectable only on subsequent imaging.

Undersøgelsestype

Interventionel

Tilmelding (Faktiske)

1667

Fase

  • Ikke anvendelig

Kontakter og lokationer

Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.

Studiesteder

      • Nuremberg, Tyskland, 90471
        • University Hosptial Nuremberg, Klinikum Nürnberg
      • Hallein, Østrig, 5400
        • Landesklinik Hallein, Salzburger Landeskliniken
      • Salzburg, Østrig, 5020
        • University Hospital Salzburg, Salzburger Landeskliniken

Deltagelseskriterier

Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.

Berettigelseskriterier

Aldre berettiget til at studere

2 år og ældre (Barn, Voksen, Ældre voksen)

Tager imod sunde frivillige

Ingen

Køn, der er berettiget til at studere

Alle

Beskrivelse

Inclusion Criteria:

  • Age 2 years or older.
  • Presentation to the emergency department following trauma or relevant joint complaint requiring plain radiographic imaging.
  • Injury involving a single anatomical region within the supported anatomical scope of the AI system.
  • Written informed consent provided by the participant or legally authorized representative, with age-appropriate assent where applicable.

Exclusion Criteria:

  • Age younger than 2 years.
  • Injuries involving multiple anatomical regions.
  • Head or cervical spine injuries.
  • Previous radiographic imaging or medical assessment for the same injury before the index presentation.
  • Contraindication to X-ray imaging, including pregnancy.
  • Lack of informed consent.

Reduced image quality was not an exclusion criterion. Multiple fractures within the same anatomical injury region were eligible.

Studieplan

Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.

Hvordan er undersøgelsen tilrettelagt?

Design detaljer

  • Primært formål: Diagnostisk
  • Tildeling: Randomiseret
  • Interventionel model: Parallel tildeling
  • Maskning: Ingen (Åben etiket)

Våben og indgreb

Deltagergruppe / Arm
Intervention / Behandling
Ingen indgriben: Standard Radiograph Interpretation Without AI

Plain radiographs are interpreted by the frontline treating physician according to routine clinical practice without access to AI output. All diagnostic, imaging, treatment, consultation, and discharge decisions remain the responsibility of the treating physician. Formal radiology reports are generally available later and are not routinely available before completion of the emergency department encounter.

Eksperimentel: AI-Assisted Radiograph Interpretation

Plain radiographs are interpreted by the frontline treating physician with access to real-time output from BoneView version 2.3.8 (Gleamer, Paris, France). The AI output is used as diagnostic decision support only; all final diagnostic, imaging, treatment, consultation, and discharge decisions remain the responsibility of the treating physician.

BoneView version 2.3.8 (Gleamer, Paris, France) analyzes DICOM radiographs and provides real-time visual annotations and classifications for supported musculoskeletal abnormalities. Physicians in the intervention group could view fracture-related findings as well as other supported outputs, including dislocations, joint effusions, and focal bone lesions.

At University Hospital Salzburg and Regional Hospital Hallein, BoneView was delivered through the Aidoc aiOS platform (version 3.24.0). At University Hospital Nuremberg, BoneView was integrated directly into the local imaging workflow.

BoneView was used as a decision-support tool and did not replace physician interpretation or the subsequent formal radiology report.

Hvad måler undersøgelsen?

Primære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
Time from Emergency Department Triage to Discharge
Tidsramme: During the index emergency department encounter (day 1).

Time in minutes from formal emergency department triage to discharge during the index encounter, compared between the AI-assisted and control groups.

During the index emergency department encounter (day 1).

Sekundære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
Missed fractures
Tidsramme: At the initial diagnostic assessment during the index emergency department encounter (day 1), with subsequent expert reference-standard adjudication.

Proportion of patient encounters with a fracture visible on the index radiographs, according to the expert-adjudicated reference standard, in which the fracture was not identified by the frontline treating physician during the initial diagnostic assessment. The reference standard is established by a radiologist and a senior orthopaedic trauma surgeon, with disagreements resolved by consensus or a third expert. Fractures identified on subsequent imaging but not visible on the original radiographs are not classified as missed radiographically visible fractures.

At the initial diagnostic assessment during the index emergency department encounter (day 1), with subsequent expert reference-standard adjudication.
Additional Diagnostic Imaging Requested
Tidsramme: During the index emergency department encounter (day 1), following initial radiographic assessment.

Proportion of patient encounters in which the treating physician requested additional diagnostic imaging during the index emergency department visit. The frequency of additional imaging requests is compared between the AI-assisted and control groups.

During the index emergency department encounter (day 1), following initial radiographic assessment.
Physician Diagnostic Confidence
Tidsramme: Measured immediately after the diagnosis

The level of confidence reported by physicians in their diagnostic decisions, measured on a Likert scale (1-10). This will compare how confident physicians feel when using AI assistance versus relying solely on their expertise.

Measured immediately after the diagnosis
Diagnostic Accuracy of Fracture/Dislocation/Effusion/Bone Lesion Detection
Tidsramme: At the time of initial diagnosis, within 2 hours of patient presentation to the orthopedic emergency unit

The primary outcome measures the diagnostic accuracy of detecting broken bones/dislocations/effusions/bone lesions using sensitivity, specificity, and the area under the receiver operating characteristic curve (AUC). Diagnostic accuracy will be compared between the AI-assisted diagnostic approach and the standard physician-only approach. The gold standard for comparison will be determined by expert consensus based on independent review by a radiologist and an orthopedic specialist.

At the time of initial diagnosis, within 2 hours of patient presentation to the orthopedic emergency unit

Samarbejdspartnere og efterforskere

Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.

Samarbejdspartnere

Publikationer og nyttige links

Den person, der er ansvarlig for at indtaste oplysninger om undersøgelsen, leverer frivilligt disse publikationer. Disse kan handle om alt relateret til undersøgelsen.

Datoer for undersøgelser

Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.

Studer store datoer

Studiestart (Faktiske)

1. oktober 2025

Primær færdiggørelse (Faktiske)

30. april 2026

Studieafslutning (Faktiske)

30. april 2026

Datoer for studieregistrering

Først indsendt

9. december 2024

Først indsendt, der opfyldte QC-kriterier

20. december 2024

Først opslået (Faktiske)

31. december 2024

Opdateringer af undersøgelsesjournaler

Sidste opdatering sendt (Faktiske)

6. november 2026

Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier

3. november 2026

Sidst verificeret

1. oktober 2026

Mere information

Begreber relateret til denne undersøgelse

Plan for individuelle deltagerdata (IPD)

Planlægger du at dele individuelle deltagerdata (IPD)?

JA

IPD-planbeskrivelse

De-identified individual participant data underlying the results reported in the primary publication will be made available to qualified researchers upon reasonable written request.

Shared data may include participant demographics, anatomical injury region, frontline physician diagnosis, AI findings, expert-adjudicated reference-standard findings, diagnostic confidence, additional imaging, and timing data used to derive the primary endpoint.

Data will be shared only for scientifically justified research purposes following review and approval of the proposed project by the study investigators and execution of an appropriate data-sharing agreement. Data sharing will comply with applicable institutional requirements, the General Data Protection Regulation (GDPR), and relevant Austrian and German data-protection legislation.

IPD-delingstidsramme

Beginning 3 months after publication of the final prespecified FAIR outcome analysis, for 5 years

IPD-delingsadgangskriterier

Scientifically sound proposal; investigator review; applicable consent, ethics, institutional and data-protection requirements; appropriate data-sharing agreement

IPD-deling Understøttende informationstype

  • STUDY_PROTOCOL
  • SAP

Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter

Studerer et amerikansk FDA-reguleret lægemiddelprodukt

Ingen

Studerer et amerikansk FDA-reguleret enhedsprodukt

Ingen

produkt fremstillet i og eksporteret fra U.S.A.

Ingen

Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .

Abonner